亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

陜西昌吉輔生物科技有限公司  

藥用輔料

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
站內(nèi)搜索
 
榮譽資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應(yīng)產(chǎn)品 > 醫(yī)藥級苯甲酸芐酯CAS號120-51-4
醫(yī)藥級苯甲酸芐酯CAS號120-51-4
單價 35.00 / 瓶對比
銷量 暫無
發(fā)貨 陜西付款后3天內(nèi)
庫存 8888瓶起訂1瓶
品牌 醫(yī)藥級苯甲酸芐酯
醫(yī)藥級 苯甲酸芐酯
藥用級 苯甲酸芐酯
現(xiàn)貨 有資質(zhì)
過期 長期有效
更新 2021-11-11 14:32
 
詳細信息

醫(yī)藥級苯甲酸芐酯CAS號120-51-4

外觀與性狀:無色油性液體帶有令人愉快的芳香氣味
密度:1.118g/mLat 20°C(lit.)
熔點:18 °C
沸點:323-324°C(lit.)
閃點:298°F
折射率:n20/D 1.568(lit.)
電導(dǎo)率(S/m,25oC):<1×10
黏度(mPa·s,20oC):8.45
水溶解性:practically insoluble
穩(wěn)定性:Stable. Substances to be avoided include strong oxidizing agents. *bustible.
儲存條件:通風(fēng)低溫干燥,避免與氧化劑共同存放
蒸汽壓:0.00025mmHg at 25°C

©2025 陜西昌吉輔生物科技有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:16425  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |